These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
427 related articles for article (PubMed ID: 31698826)
21. Revisiting the framework of the National Institute on Aging-Alzheimer's Association diagnostic criteria. Carrillo MC; Dean RA; Nicolas F; Miller DS; Berman R; Khachaturian Z; Bain LJ; Schindler R; Knopman D; Alzheimers Dement; 2013 Sep; 9(5):594-601. PubMed ID: 24007744 [TBL] [Abstract][Full Text] [Related]
22. Critical Comparison of Different Biomarkers for Alzheimer's Disease in a Clinical Setting. Weise D; Tiepolt S; Awissus C; Hoffmann KT; Lobsien D; Kaiser T; Barthel H; Sabri O; Gertz HJ J Alzheimers Dis; 2015; 48(2):425-32. PubMed ID: 26402006 [TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of the use of biomarkers in cerebrospinal fluid for Alzheimer's disease. Valcárcel-Nazco C; Perestelo-Pérez L; Molinuevo JL; Mar J; Castilla I; Serrano-Aguilar P J Alzheimers Dis; 2014; 42(3):777-88. PubMed ID: 24916543 [TBL] [Abstract][Full Text] [Related]
25. The National Institute on Aging-Alzheimer's Association Framework on Alzheimer's disease: Application to clinical trials. Cummings J Alzheimers Dement; 2019 Jan; 15(1):172-178. PubMed ID: 29936146 [TBL] [Abstract][Full Text] [Related]
26. Preclinical AD predicts decline in memory and executive functions in subjective complaints. van Harten AC; Smits LL; Teunissen CE; Visser PJ; Koene T; Blankenstein MA; Scheltens P; van der Flier WM Neurology; 2013 Oct; 81(16):1409-16. PubMed ID: 24049134 [TBL] [Abstract][Full Text] [Related]
30. [Biomarker of dementia: clinical and preclinical diagnosis]. Shoji M Nihon Rinsho; 2012 May; 70(5):857-63. PubMed ID: 22620013 [TBL] [Abstract][Full Text] [Related]
31. Patterns of Cortical and Subcortical Amyloid Burden across Stages of Preclinical Alzheimer's Disease. Edmonds EC; Bangen KJ; Delano-Wood L; Nation DA; Furst AJ; Salmon DP; Bondi MW; J Int Neuropsychol Soc; 2016 Nov; 22(10):978-990. PubMed ID: 27903335 [TBL] [Abstract][Full Text] [Related]
32. On the path to 2025: understanding the Alzheimer's disease continuum. Aisen PS; Cummings J; Jack CR; Morris JC; Sperling R; Frölich L; Jones RW; Dowsett SA; Matthews BR; Raskin J; Scheltens P; Dubois B Alzheimers Res Ther; 2017 Aug; 9(1):60. PubMed ID: 28793924 [TBL] [Abstract][Full Text] [Related]
33. Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics. Prestia A; Caroli A; Wade SK; van der Flier WM; Ossenkoppele R; Van Berckel B; Barkhof F; Teunissen CE; Wall A; Carter SF; Schöll M; Choo IH; Nordberg A; Scheltens P; Frisoni GB Alzheimers Dement; 2015 Oct; 11(10):1191-201. PubMed ID: 25646957 [TBL] [Abstract][Full Text] [Related]
34. NIA-AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkers. Vos SJB; Gordon BA; Su Y; Visser PJ; Holtzman DM; Morris JC; Fagan AM; Benzinger TLS Neurobiol Aging; 2016 Aug; 44():1-8. PubMed ID: 27318129 [TBL] [Abstract][Full Text] [Related]
35. Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease. Prvulovic D; Hampel H Clin Chem Lab Med; 2011 Mar; 49(3):367-74. PubMed ID: 21342022 [TBL] [Abstract][Full Text] [Related]
36. Usefulness of biomarkers in the diagnosis and prognosis of early-onset cognitive impairment. Balasa M; Sánchez-Valle R; Antonell A; Bosch B; Olives J; Rami L; Castellví M; Molinuevo JL; Lladó A J Alzheimers Dis; 2014; 40(4):919-27. PubMed ID: 24577466 [TBL] [Abstract][Full Text] [Related]
37. Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias. de Souza LC; Lamari F; Belliard S; Jardel C; Houillier C; De Paz R; Dubois B; Sarazin M J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):240-6. PubMed ID: 20802215 [TBL] [Abstract][Full Text] [Related]
38. The Role of Cerebrospinal Fluid Biomarkers in the Evolution of Diagnostic Criteria in Alzheimer's Disease: Shortcomings in Prodromal Diagnosis. Szalárdy L; Zádori D; Klivényi P; Vécsei L J Alzheimers Dis; 2016 May; 53(2):373-92. PubMed ID: 27163812 [TBL] [Abstract][Full Text] [Related]
39. Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease. Kang JH; Vanderstichele H; Trojanowski JQ; Shaw LM Methods; 2012 Apr; 56(4):484-93. PubMed ID: 22503777 [TBL] [Abstract][Full Text] [Related]
40. Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the concept. Epelbaum S; Genthon R; Cavedo E; Habert MO; Lamari F; Gagliardi G; Lista S; Teichmann M; Bakardjian H; Hampel H; Dubois B Alzheimers Dement; 2017 Apr; 13(4):454-467. PubMed ID: 28188032 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]